Integra LifeSciences Holdings Corporation share price logo

Integra LifeSciences Holdings Corporation

NASDAQ: IART

Small Cap

$18.34

+0.10

(+0.55%)

as on

Integra LifeSciences Holdings Corporation Stock Performance

as on August 15, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $17.75
    $18.45
    downward going graph

    3.22%

    Downside

    0.60%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.70
    $20.49
    downward going graph

    52.56%

    Downside

    11.72%

    Upside

    downward going graph

Integra LifeSciences Holdings Corporation share price movements today

Previous Close
$18.24
Open
$18.10
Volume
416.7K
Day's Low - High
$17.75 - $18.45
52 Week Low - High
$8.70 - $20.49

Integra LifeSciences Holdings Corporation Historical Returns

1 Month Return
-0.87 %
3 Month Return
+ 25.79 %
1 Year Return
+ 33.92 %
3 Year Return
-58.17 %
5 Year Return
-74.32 %

Integra LifeSciences Holdings Corporation Stock Fundamentals & Key Indicators

Check Integra LifeSciences Holdings Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

2.457

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.7128

EBITDA

316.9M

Revenue (TTM)

1.6B

Profit Margin

-0.44%

Return On Equity TTM

-0.70%

Integra LifeSciences Holdings Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Integra LifeSciences Holdings Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.4B-74.32%NA-0.44%NA
BUY$133.2B29.62%36.0914.43%1%
BUY$53.4B-18.2%55.115.43%NA
BUY$116.1B-29.42%24.3313.20%3.1300000000000003%
BUY$191.9B-9.58%35.4311.65%2.26%

Stock Returns calculator for Integra LifeSciences Holdings Corporation Stock including INR - Dollar returns

The Integra LifeSciences Holdings Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Integra LifeSciences Holdings Corporation investment value today

Current value as on today

₹1,47,176

Returns

₹47,176

(+47.18%)

Returns from Integra LifeSciences Holdings Corporation Stock

₹34,655 (+34.65%)

Dollar Impact

₹12,521 (+12.52%)

Analyst Recommendation on Integra LifeSciences Holdings Corporation Stock

Based on 20 analysts

BUY

50.00%

Buy

35.00%

Hold

15.00%

Sell

Based on 20 analysts, 50% of analysts recommend a 'BUY' rating for Integra LifeSciences Holdings Corporation. Average target price of $19.56

Integra LifeSciences Holdings Corporation Share Price Target

Get share price movements and forecasts by analysts on Integra LifeSciences Holdings Corporation.

What analysts predicted

6.24%UPSIDE

Target Price

$19.56

Current Price

$18.34

Analyzed by

20 Analysts

Target

$19.56

Integra LifeSciences Holdings Corporation target price $19.56, a slight upside of 6.24% compared to current price of $18.34. According to 20 analysts rating.

Indian Investors' Interest in Integra LifeSciences Holdings Corporation Stock

Search interest for Integra LifeSciences Holdings Corporation Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:15% versus previous 30 day period

Integra LifeSciences Holdings Corporation Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
368
418
380
442
382
415
402
434
391
418
Gross Profit
206
225
200
249
194
209
226
215
224
219
Operating Income
3
-3
-8
35
-15
-512
40
556
40
19
EBITDA
38
40
34
79
25
-472
54
65
62
65
Interest Expense
13
18
19
18
20
21
22
23
26
22
Depreciation
30
36
35
37
37
37
38
38
38
38
Income Before Tax
-5
-15
-20
22
-30
-530
-6
4
-2
4
Income Tax Expense
-1
-2
-9
3
-4
-46
-1
6
2
0
Net Income
-3
-12
-10
19
-25
-484
-5
-1
-4
4
Net Profit Margin
-0.89%
-2.97%
-2.81%
4.39%
-6.61%
-116.47%
-1.34%
-0.39%
-1.18%
1.07%

Integra LifeSciences Holdings Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
992
1,188
1,472
1,517
1,371
1,542
1,557
1,541
1,610
1,635
Gross Profit
642
752
900
952
851
944
970
884
882
845
Operating Income
115
44
110
93
151
197
238
111
28
68
EBITDA
231
135
241
223
267
366
384
255
193
-326
Interest Expense
25
35
64
53
71
50
49
51
70
86
Depreciation
-
88
110
109
116
16
118
123
140
151
Income Before Tax
90
11
57
60
93
214
213
81
-18
-563
Income Tax Expense
15
-53
-3
9
-40
45
33
13
-11
-47
Net Income
74
64
60
50
133
169
180
67
-6
-516
Net Profit Margin
7.52%
5.45%
4.13%
3.31%
9.76%
10.96%
11.59%
4.39%
-0.43%
-31.58%

Integra LifeSciences Holdings Corporation Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-12
-10
19
-25
-484
-5
-1
-4
4
Operating Cash Flow
40
22
50
-11
8
40
11
9
22
Investing Cash Flow
-322
-10
-4
-35
-21
-15
-34
-14
-43
Financing Cash Flow
-93
-19
-7
35
-21
-10
24
8
-1
Change in Cash
-376
0
31
-7
-21
14
2
1
-23

Integra LifeSciences Holdings Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
64
60
50
133
169
180
67
-6
-516
Operating Cash Flow
114
199
231
203
312
264
139
129
50
Investing Cash Flow
-1,221
-49
-162
-68
-161
-58
-94
-390
-108
Financing Cash Flow
1,168
-180
-8
121
-98
-251
-229
237
28
Change in Cash
72
-36
60
271
43
-56
-180
-30
-11

Global Institutional Holdings in Integra LifeSciences Holdings Corporation

Funds
Holdings
Vanguard Group Inc
9.27%
Vanguard Capital Management, LLC
3.72%
State Street Corp
3.71%
Dimensional Fund Advisors, Inc.
3.57%
The Goldman Sachs Group Inc
2.41%

Integra LifeSciences Holdings Corporation News & Key Events

  • img

    Today's Timeline - 09 July

    Thu, 08:00 PM

    -

    Integra LifeSciences reports 13.7% earnings yield, outperforming industry; shares up 31.4% over the past year.

Insights on Integra LifeSciences Holdings Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -4.61M → 4.48M (in $), with an average increase of 203.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, IART stock has moved up by 62.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 391.91M → 418.76M (in $), with an average increase of 6.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IART has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Stryker Corporation has given 16.3% return, outperforming this stock by 73.8%

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
OrganisationIntegra LifeSciences Holdings Corporation
Headquarters1100 Campus Road, Princeton, NJ, United States, 08540
IndustryMedical Devices
CEODr. Stuart M. Essig Ph.D.
E-voting on sharesClick here to vote

Key Management of Integra LifeSciences Holdings Corporation

Name

Title

Mr. Robert T. Davis Jr.

Executive Vice President of Tissue Reconstruction and Distributed Technologies

Mr. Teshtar Elavia

Corporate VP & Chief Technology Officer

Christopher Ward

Senior Director of Investor Relations

Laurene Isip

Vice President of Global Corporate Communications & Public Relations

Ms. Lea Daniels Knight

Executive VP & CFO

Mr. Michael J. McBreen

Executive VP & Chief Commercial Officer

Mr. Harvinder Pal Singh

Executive VP & President of International Business

Mr. Jeffrey A. Mosebrook

Senior VP of Finance & Principal Accounting Officer

Mr. Michael D. Hutchinson

Executive VP, Chief Legal Officer & Secretary

Dr. Stuart M. Essig Ph.D.

CEO, President & Chairman

FAQs

What is Integra LifeSciences Holdings Corporation share price today?

Integra LifeSciences Holdings Corporation share price today is $18.34 as on at the close of the market. Integra LifeSciences Holdings Corporation share today touched a day high of $18.45 and a low of $17.75.

What is the 52 week high and 52 week low for Integra LifeSciences Holdings Corporation share?

Integra LifeSciences Holdings Corporation share touched a 52 week high of $20.49 on and a 52 week low of $8.70 on . Integra LifeSciences Holdings Corporation stock price today i.e. is closed at $18.34,which is 10.49% down from its 52 week high and 110.80% up from its 52 week low.

What is Integra LifeSciences Holdings Corporation's market capitalisation today?

Integra LifeSciences Holdings Corporation market capitalisation is $0.00T as on .

How to invest in Integra LifeSciences Holdings Corporation Stock (IART) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Integra LifeSciences Holdings Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Integra LifeSciences Holdings Corporation Shares that will get you 0.0818 shares as per Integra LifeSciences Holdings Corporation share price of $18.34 per share as on August 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy Integra LifeSciences Holdings Corporation Stock (IART) from India?

Indian investors can start investing in Integra LifeSciences Holdings Corporation (IART) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Integra LifeSciences Holdings Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Integra LifeSciences Holdings Corporation share’s latest price of $18.34 as on August 15, 2026 at 8:46 am IST, you will get 0.5453 shares of Integra LifeSciences Holdings Corporation. Learn more about fractional shares .

What are the returns that Integra LifeSciences Holdings Corporation has given to Indian investors in the last 5 years?

Integra LifeSciences Holdings Corporation stock has given -74.32% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?